News coverage about Cantel Medical (NYSE:CMD) has been trending somewhat negative recently, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cantel Medical earned a daily sentiment score of -0.05 on Accern’s scale. Accern also gave news stories about the company an impact score of 44.7216923309313 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

CMD opened at $96.25 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.44 and a quick ratio of 1.52. The stock has a market capitalization of $3.99 billion, a price-to-earnings ratio of 46.27 and a beta of 1.09. Cantel Medical has a 12 month low of $73.90 and a 12 month high of $130.92.

Cantel Medical (NYSE:CMD) last posted its quarterly earnings results on Thursday, May 31st. The company reported $0.60 EPS for the quarter, meeting the consensus estimate of $0.60. The company had revenue of $217.27 million during the quarter, compared to analysts’ expectations of $222.00 million. Cantel Medical had a return on equity of 17.07% and a net margin of 10.74%. sell-side analysts forecast that Cantel Medical will post 2.5 EPS for the current fiscal year.

The firm also recently declared a Semi-Annual dividend, which was paid on Tuesday, July 31st. Shareholders of record on Tuesday, July 17th were issued a $0.085 dividend. The ex-dividend date of this dividend was Monday, July 16th. Cantel Medical’s dividend payout ratio (DPR) is 8.17%.

Separately, ValuEngine upgraded Cantel Medical from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention products and services for the healthcare market worldwide. The company operates through four segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

See Also: Price to Earnings Ratio (PE)

Insider Buying and Selling by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with's FREE daily email newsletter.